We go to the audit
Release time:
2020-07-22
We went to audit
# May 17 -19 . As a member of the supplier audit team, I visited Changzhou Ruiming, Wuxi Yangjian Huaqiang, Suzhou Haishun, Zhejiang Duoling Pharmaceutical Packaging and other companies with my colleagues and conducted a series of audit work.
As one of the key elements of production, the quality and stability of raw materials and auxiliary materials directly determine the stability of the final product quality. In order to ensure the stability of product quality, our manufacturers conduct supplier audits of raw and auxiliary package suppliers every year. This is an on-site audit, including verifying the authenticity of the supplier's qualification documents and inspection reports, whether they have inspection conditions, etc., as well as reviewing its personnel structure, plant facilities and equipment, material management, production process and production management, and quality control laboratory equipment, instruments, document management, etc.
This is my first time to participate in the audit, although I made a corresponding inspection plan for the basic situation of all the suppliers to be inspected before departure. However, once you arrive at the scene, you will still be nervous and do not know where to start. With the warm reception of the representatives of the supply side, our audit work was carried out in an orderly manner.
First of all, we went to the manufacturers of raw materials and chemical raw materials. Before entering the production area, the reception staff of the other party gave us full oral safety education and issued safety helmets, demonstrating the safety awareness that a chemical plant should have. Their production area and office area have obvious regional isolation, effectively avoid cross-contamination. However, some parts of the production site are not doing very well. For example, the unloading position of the raw materials delivered from the warehouse is too random, which is just the place where solar energy is exposed. The label of the raw materials during feeding was removed in advance. In contrast, our factory has done a better job of on-site management. When the raw materials come, there will also be a special unloading position. The labels of the materials will be on the materials until the end of feeding, so as to avoid confusion. We raised these issues with the manufacturer, and the other party accepted them modestly, dealt with them in a timely manner, and said that they would provide rectification reports after all rectifications.
may be an old customer. The manufacturers of composite film (bag) and aluminum foil for drug packaging are a little too casual in reception. We arrived at the factory on the same day but could not find the reception staff. On the spot, there is a sharp contrast between the packaging material manufacturers and our pharmaceutical companies. Although they are also in the D area, their spot is slightly messy and their concept of clearing the spot is somewhat vague. Due to continuous production, the equipment site is easy to leave materials, and the lack of fixed position is slightly messy. They also made rectification immediately after the site was put forward. For our pharmaceutical factory, it is also necessary to change what we have and encourage what we have not.
The third enterprise we went to is a large listed company. Not only can the production and inspection equipment meet the production and inspection requirements, but also the production line is fully automatic production of industry 4.0 , which is fully automated from equipment operation, material and product transportation. In the workshop, the quality of products is also monitored in real time through the central control room, and the positioning of various items is also standardized. The warehouse is a 4 -storey three-dimensional library, which realizes unmanned operation. Their laboratory even has a separate aluminum plastic machine to do challenging experiments, reflecting their pursuit of product quality excellence. All these are worth learning. The wave of industrial automation upgrading is constantly advancing. Although we have not yet entered that stage, we must always maintain our own improvement to meet this wave.
The last company is an enterprise that produces PVC medicinal hard tablets and various composite hard tablets and composite high-barrier packaging materials. Our host is their QC supervisor. To my surprise, their supervisor QC was born in a health school and took part in the inspection work, but he was quite familiar with their process flow and process parameters. This also makes us realize that no matter what position we are in, we should actively learn what we can come into contact with, especially for the process flow and process parameters in production, showing a kind of professionalism for our own industry. During the audit, we found that their workshop also has a special access to visit, each door has access control, for access control is very good. This is where we can learn from. For a workshop, access control is very important, which can effectively avoid problems such as personnel stringing and pollution.
As a production enterprise, our pharmaceutical factory also accepts the audit of our customers every year. Through this rare audit opportunity, I can look at the supplier from the customer's point of view, from which I can objectively see many problems in daily work and production. The first point is that for the reception of customers, special personnel and sufficient relevant information can make customers have a good impression on us; on the production site, various small details determine the quality of the product and whether the production process meets the customer's standards; records and various inspection reports show the true quality of the product. Taking the essence and removing the dross, we will apply the experience gained during this audit to our daily production work, which will certainly give a great impetus to our future work. (Zheng Nan)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page